Cart
sales@molnova.com
Home - Products - Cell Cycle/DNA Damage - ROCK - CID-5056270

CID-5056270

CAS No. 681173-76-2

CID-5056270( —— )

Catalog No. M33971 CAS No. 681173-76-2

CID-5056270 has anticancer activity and can inhibit lung cancer, anal cancer, bladder cancer, cervical cancer, vulvar cancer, penile cancer, Burkitt's lymphoma, breast cancer and bone cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 446 In Stock
5MG 440 In Stock
10MG 613 In Stock
25MG 905 In Stock
50MG 1209 In Stock
100MG 1609 In Stock
200MG 2167 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    CID-5056270
  • Note
    Research use only, not for human use.
  • Brief Description
    CID-5056270 has anticancer activity and can inhibit lung cancer, anal cancer, bladder cancer, cervical cancer, vulvar cancer, penile cancer, Burkitt's lymphoma, breast cancer and bone cancer.
  • Description
    CID-5056270 has anticancer activity and can inhibit lung cancer, anal cancer, bladder cancer, cervical cancer, vulvar cancer, penile cancer, Burkitt's lymphoma, breast cancer and bone cancer. It can be used to study hypertension, Alzheimer's disease and arteriosclerosis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    ROCK
  • Recptor
    ROCK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    681173-76-2
  • Formula Weight
    339.37
  • Molecular Formula
    C17H13N3O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(C(=O)C1OC=2C(OC1)=CC=CC2)C3=NC(=CS3)C=4C=CN=CC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Thiazovivin

    Thiazovivin (Tzv) is a novel ROCK inhibitor with IC50 of 0.5 μM, promotes hESC survival after single-cell dissociation.

  • (1R,2S)-VU0155041

    (1R,2S)-VU0155041 is a partial agonist of mGluR4(EC50 of 2.35 μM).

  • MD 39-AM

    Anticytokinin activity was evaluated by 50% of the callus growth on the medium with kinetin but without anti-cytokinin

Sign In Join Free